Skip to content

Stories in the news media about CoMotion and the UW spinoffs and innovations we’ve supported.

  • Parent Project Muscular Dystrophy Invests $350,480 in Myosana Therapeutics to Support Non-Viral Gene Therapy Development

    Parent Project Muscular Dystrophy Staff
    Myosana logo
  • Icosavax stock skyrockets 200% on first day of trading for newly public Seattle biotech company

    Taylor Soper
    icosavax nasdaq NEWS
  • ‘We’ve been instrumental’: How Seattle became a hub for COVID-19 vaccine research

    Charlotte Schubert
  • New protein folding technology from UW lab rivals DeepMind, promises to accelerate research

    Charlotte Schubert
    Rose-TTAFold
  • Toyota's Woven Planet Acquires HD Mapping Startup Carmera

    Kirsten Korosec
    Carmera Cobra_Detroit_PoC
  • Meet the 4 new startups joining a fintech incubator run by BECU and UW in Seattle

    Laurel Deppen
    BECU FTIC 2021
  • Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

    Charlotte Schubert
    ICOSAVAX NEWS
  • Providence spinout Tegria acquires Seattle healthcare AI startup KenSci

    Charlotte Schubert
    Tegria KenSci news
  • Univ. of Washington and Sana researchers use gene editing to prep stem cells for heart repair

    Charlotte Schubert
    UW Institute for Stem Cell Regen Med lab
  • Lyell Immunopharma shares fall in trading debut

    Ciara Linnane
    lyell news